0 01/05/2023 30/04/2024 2024-04-30 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-05-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 14069254 2023-05-01 2024-04-30 14069254 2024-04-30 14069254 2023-04-30 14069254 bus:RegisteredOffice 2023-05-01 2024-04-30 14069254 bus:Director1 2023-05-01 2024-04-30 14069254 core:WithinOneYear 2024-04-30 14069254 bus:Director1 2023-04-30 14069254 bus:Director1 2024-04-30 14069254 bus:Micro-entities 2023-05-01 2024-04-30 14069254 bus:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 14069254 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 14069254 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 14069254 bus:FullAccounts 2023-05-01 2024-04-30
Company registration number: 14069254
Rubiepharma Ltd
Unaudited filleted financial statements
30 April 2024
Rubiepharma Ltd
Contents
Directors and other information
Statement of financial position and notes to the financial statements
Rubiepharma Ltd
Directors and other information
Director Mr Jaafar Al-Rubie
Company number 14069254
Registered office 11 Castleton Avenue
Wembley
Middlesex
HA9 7QH
Rubiepharma Ltd
Statement of financial position
30 April 2024
£
Fixed assets 1,170
_______
Current assets 3,416
Creditors: amounts falling due within one year ( 2,751)
_______
Net current assets 665
_______
Total assets less current liabilities 1,835
Accruals and deferred income ( 650)
_______
Net assets 1,185
_______
Capital and reserves 1,185
_______
Notes to the financial statements
Rubiepharma Ltd
Year ended 30 April 2024
1. Directors advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
Year ended
Balance brought forward Advances /(credits) to the director Balance o/standing
£ £ £
Mr Jaafar Al-Rubie 5,518 ( 2,542) 2,976
_______ _______ _______
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 23 January 2025 , and are signed on behalf of the board by:
Mr Jaafar Al-Rubie
Director
Company registration number: 14069254
The company is a private company limited by shares, registered in England & Wales.